Biotechnology for a better quality of life in a sustainable society - PowerPoint PPT Presentation

Loading...

PPT – Biotechnology for a better quality of life in a sustainable society PowerPoint presentation | free to view - id: 8c8e7-MjAwY



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Biotechnology for a better quality of life in a sustainable society

Description:

Biotechnology for a better quality of life in a sustainable society. EuropaBio ... Biotechnology to be the basis for the knowledge based economy ... – PowerPoint PPT presentation

Number of Views:165
Avg rating:3.0/5.0
Slides: 19
Provided by: johanvanh
Category:

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Biotechnology for a better quality of life in a sustainable society


1
EuropaBio The European Association for
Bioindustries

Biotechnology for a better quality of life in a
sustainable society
2
The European Strategy on Life Sciences and
Biotechnology

  • Excellent
  • European
  • Visionary
  • Pragmatic
  • Concrete actions what who when
  • Respecting society values
  • Respecting regulatory oversight and principles
  • Based on facts
  • Taking up the world challenges, also the
    developing world
  • Seeking coherence
  • Based on dialogue
  • In the whole of Europe, across policies, sectors
    and actors
  • And has been endorsed by the European Commission,
    the European Parliament and the heads of state of
    all Member States of the European Union

3

Expected Results
  • Biotechnology to be the basis for the knowledge
    based economy
  • Biotechnology to create jobs and wealth
  • Biotechnology to cure and prevent diseases.
  • Biotechnology to increase survival
  • Biotechnology to improve patients quality of
    life
  • Biotechnology to help the environment (KYOTO)
  • Biotechnology to feed the world
  • Biotechnology to return to the plant based
    economy
  • Biotechnology to optimise renewable resources
  • Biotechnology to be competitive

4
Biotechnology the invisible revolution
EuropaBio The European Association for
Bioindustries
Corn is corn Soya is soya
BioPlastic is plastic BioDiesel is diesel.
  • Products are products whatever the production
    technology.

Medicines are medicines
5
Arts and skills of the bio-entrepreneur Minimize
entrepreneurial risk, maximize societal value
Political risk
Research risks
IPR risks
VALUE
Financial risks
Regulatory risks
RISK
Market risks
TIME LINE
6
Arts and skills of the bio-entrepreneur Minimize
entrepreneurial risk, maximize societal value
Political opportunity
Research risks
IPR risks
VALUE
Financial risks
Regulatory risks
RISK
Market risks
TIME LINE
7
European Biotech Companies Impact on growth
(products)
… less products in development
Lower RD budgets in Europe, means…
8
Chicken and egg
  • Innovation makes money from the knowledge.
  • Research is turning money in knowledge.

9
What is needed?
  • Full and complete implementation of the European
    life sciences and Biotechnology Strategy across
    Europe

10

Are We Ready to Be Leading?
  • Is the Healthcare Legislation in EU including
    Member States?
  • Classical Advanced
  • ? Clear Yes No
  • ? Providing predictable outcome Yes?
    Not yet
  • ? Result oriented Yes Not yet
  • ? Provide access to the medicines? Not always
    or Not yet
  • always not everywhere
  • ? Patient Oriented Not really Not yet
  • Is the Registration System Adapted to the new
    approaches?

11

Are We Ready to Be Leading?
  • Is Research Stimulated?
  • ? IMI FP 7
  • Cells Tissues
  • Is Research Inhibited
  • ? Stem Cells in certain Areas
  • ? Ethical Discussions

12

Are We Ready to Be Leading?
  • Is Entrepreneurship and innovation stimulated and
    sustained ?
  • ? SMEs YIC FP 7
  • CIP
  • Are innovative products welcomed or suspect?
  • ? Use of Commitology as vote on science?
  • ? 4th Hurdle versus access and reward?

13
European Biotech Industry delivers
  • New medicines 20 of todays medicines are
    biotech and 50 of medicines in the pipeline are
    biotech
  • New strategies against unmet medical needs.
  • New plants for the benefit of the environment,
    the consumer, the farmer, the white
    biotechnology, the patient.
  • New hope for patients, through improved
    diagnostic tests
  • New hope for Europe through diagnostics for BSE
  • New hope for Europe through elimination!!! of
    Rabies.
  • New knowledge on the cause of diseases

14
EMEA Opens arms to biotech SMEs
  • 100 reduction on administrative assistance
  • 90 fee reductions on scientific advice and
    inspection
  • Fee deferrals after authorisation
  • No fee if no success conditional on scientific
    advice
  • EMEA Buddy system

15

Innovation for the benefit of patients

Human Insulin First application of Biotech in
medicine Recombinant human growth hormone First
Synthetic human growth hormone with no risk of
CJD infection Recombinant interferon beta
Enabled real progress in treating Multiple
Sclerosis Recombinant erythropoietin
(EPO) Revolutionized the treatment of anemia,
eliminating viral infections including AIDS and
Hepatitis B or C Monoclonal antibodies for the
treatment of cancer Development of drugs
targeting specific types of cancer cells
Herceptin (Trastuzumab) for breast cancer
.
16
Our Corporate Members
17
Our Corporate Members
18
Biotechnology for a quality of life in a
sustainable society
www.europabio.org
About PowerShow.com